Friday, 03 May 2024
Delmar Pharmaceuticals Inc.
11:40 | 15/2/18
PR Newswire
VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 14, 2018 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new cancer therapies, announced its ...
more»
04:32 | 13/2/18
Simply Wall St
For DelMar Pharmaceuticals Inc's (NASDAQ:DMPI) shareholders, and also potential investors in the stock, understanding how the stock's risk and return characteristics can impact your portfolio is important.
more»
05:07 | 28/1/18
FLBC News
Checking in on the signals for Delmar Pharmaceuticals Inc (DMPI), we have recently recorded the Chaikin Oscillator above zero.
more»
03:03 | 24/1/18
Norman Weekly
Analysts expect DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) to report $-0.15 EPS on February, 9.They anticipate $0.02 EPS change or 15.38% from last quarter's $-0.13 EPS.
more»
06:30 | 23/1/18
Nasdaq Tribune
Shares of DelMar Pharmaceuticals, Inc, (NASDAQ: DMPI) exhibits a change of -2.86% to $1.36 in an early morning trading session today.
more»
05:07 | 23/1/18
NASDAQ Times
DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) shares reduced -2.69% to trade at $1.36. Expecting these factors, the firm is standing on a contradictory position.
more»
03:26 | 23/1/18
Alpha Beta Stock
Dow Jones industrial average futures declined 33 points and briefly fell as much as 101 points. S&P 500 and Nasdaq 100 futures dropped 2 points and 8 points, respectively.
more»
01:01 | 23/1/18
Post Analyst
According to 2 stock analysts, DelMar Pharmaceuticals, Inc., is being kept at an average Outperform, rating, with at least 8.87% of shares outstanding that are currently legally short sold.
more»
04:22 | 20/1/18
StockNewsGazette
Recent insider trends for DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) have caught the attention of investors. Insider activity is often a strong indicator of future performance in a stock, and if the data on DMPI is anything to go by, investors should ...
more»
00:26 | 19/1/18
ExpertGazette
Delmar Pharmaceuticals Inc (NASDAQ:DMPI) shares traded -8.39% down during most recent session to reach at the closing price of $1.42.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |